Exelixis Inc. Common Stock vs Fifth Third Bancorp Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while Fifth Third Bancorp Common Stock trades at $50.53 (market cap $45.98B). The key difference: Fifth Third Bancorp Common Stock is far larger — about 3.1× Exelixis Inc. Common Stock's market cap, and Fifth Third Bancorp Common Stock pays a 3.31% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Fifth Third Bancorp Common Stock for 1 Days on average.
| EXEL | FITB | |
|---|---|---|
Market Cap | $14.62B | $45.98B |
Volume | 2,684,957 | 10,522,320 |
Sector | Health | Financials |
52-Week High | $59.13 | $59.37 |
52-Week Low | $34.54 | $40.36 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.95B | $63.85B |
Dividend Yield | — | 3.31% |
Trailing returns across standard periods
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Fifth Third Bancorp provides retail and commercial banking, lending, payments, and wealth management services in the United States.
Read more on FITB →